Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
1999
Serum Cyclosporine Concentration and Risk of Acute Graft-versus-Host Disease after Allogeneic Marrow Transplantation
1988
Higher Risk of Cytomegalovirus and Aspergillus Infections in Recipients of T Cell–Depleted Unrelated Bone Marrow: Analysis of Infectious Complications in Patients Treated with T Cell Depletion Versus Immunosuppressive Therapy to Prevent Graft-versus-Host Disease
2007
Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP)
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Chronic graft-versus-host disease: clinical manifestation and therapy
2001
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: Risk factors and survival
2000
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Weight loss and malnutrition in patients with chronic graft-versus-host disease
2002
A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease
2001
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
1998
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Animal models of autoimmunity and their relevance to human diseases
2000 StandoutNobel
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Nutritional and metabolic support in patients undergoing bone marrow transplantation
2002
TFOS DEWS II pathophysiology report
2017 Standout
Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation
2005
Chronic graft-versus-host disease: A prospective cohort study
2003
Chronic graft-versus-host disease
2003 Standout
Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation
2000
TFOS DEWS II Epidemiology Report
2017 Standout
Thalidomide for the Treatment of Chronic Graft-versus-Host Disease
1992
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial
2005
Development and validation of a scale to measure symptoms of chronic graft-versus-host disease
2002
Graft-versus-host disease
2009 Standout
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1999
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
2004
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: Effect on chronic graft-vs.-host disease and long-term survival
1999
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
2003
Health, Functional Status, and Employment of Adult Survivors of Bone Marrow Transplantation
1991
Hematopoietic Stem-Cell Transplantation
2006 Standout
Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease
2001
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Orderly hematopoietic development of induced pluripotent stem cells via Flk‐1+ hemoangiogenic progenitors
2009 StandoutNobel
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study
1988 StandoutNobel
Bone Marrow Transplantation
1994
Donor–recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation
2011
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
2002
Quality of Umbilical Cord Blood CD34 + Cells in a Double-Compartment Freezing Bag Cryopreserved without a Rate-Controlled Programmed Freezer
2007 StandoutNobel
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Previous donor pregnancy as a risk factor for acute graft‐versus‐host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation
1990
Cyclosporine
1989 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
2001
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Development of a prognostic model for grading chronic graft-versus-host disease
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant
2003
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
1985
NK CELL RECOGNITION
2004 Standout
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation
1986
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
2002
Granulocyte–colony-stimulating factor (G-CSF)–primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF–mobilized peripheral blood stem cells
2001
Infections in bone marrow transplant recipients
1986
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Acute and chronic graft-versus-host disease in man
1986
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
2002
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation
1998
Graft-vs.-Host Disease
1997
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Duration of immunosuppressive treatment for chronic graft-versus-host disease
2004
Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation
1990
Peripheral Blood Stem Cell Transplantations: Past, present and future
1993
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
2003
Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease
1999
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide
1997
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
How I treat chronic graft-versus-host disease
2001
Graft‐versus‐Host Disease
1985
Nutrition Support in Bone Marrow Transplant Recipients
1993
Novel therapeutics for the treatment of graft-versus-host disease
2002
Female marrow donors increase the risk of acute graft‐versus‐host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum
1986
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
2002
Treatment of Chronic Graft-Versus-Host Disease With Clofazimine
1997
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
1991
Works of ER Farmer being referenced
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
1993
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]
1992
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]
1992
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
1989
Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow
1984
Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow
1984
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
1989
Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial
1990
Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial
1990